The BIOINTRAFIX brand, founded in 2004 (Belgium), from 2466 sister brands and 17477 competing brands. BIOINTRAFIX is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York BIOINTRAFIX belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(BIOINTRAFIX)
over 5 years*
USD 159.07